Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Ipsen CFO: 'We Need To Stay Focused' So Didn't Bid For Onivyde ex-US Rights
Apr 28 2018
•
By
Sten Stovall
Ipsen Is Busy planning Cabometyx's launch In the EU for use in first-line kidney cancer • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from New Products
More from Scrip